Ovarian Cancer Pipeline Analysis

Publish Date:- Aug-2013      No Of Pages (660)

Electronic Access - Single User License $1800 Buy Now
CD-ROM Mail Delivery $3600Buy Now
Hard Copy Mail Delivery $3600 Buy Now
Electronic Access - Multi-User License $6000 Buy Now


Ovarian Cancer Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Ovarian Cancer. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each drug profile in development phase enables the reader to identify and understand the therapeutics associated with the Ovarian Cancer disease. The information for particular drug in development process is represented in the form of tables and detailed analysis including the available Pharmacodynamics and Pharmacokinetics results.

This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the drug development process. Report also helps drug development organisation to keep track record the ongoing drug profiles being developed by their key competitor in the industry.

Following parameters for each drug profile in development phase are covered in “Ovarian Cancer Pipeline Analysis” research report:

  • Drug Profile Overview
  • Active Indication
  • Phase of Development
  • Country for Clinical Trial
  • Owner / Originator/ Licensee/Collaborator
  • Administrative Route
  • Drug Class
  • Patent Information
  • Molecular Formula
  • Pharmodynamics
  • Pharmacokinetics
  • Brand Names
  • Development Agreements
  • ATC Codes


Ovarian Cancer Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Ovarian Cancer. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each drug profile in development phase enables the reader to identify and understand the therapeutics associated with the Ovarian Cancer disease. The information for particular drug in development process is represented in the form of tables and detailed analysis including the available Pharmacodynamics and Pharmacokinetics results.

This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the drug development process. Report also helps drug development organisation to keep track record the ongoing drug profiles being developed by their key competitor in the industry.

Following parameters for each drug profile in development phase are covered in “Ovarian Cancer Pipeline Analysis” research report:

  • Drug Profile Overview
  • Active Indication
  • Phase of Development
  • Country for Clinical Trial
  • Owner / Originator/ Licensee/Collaborator
  • Administrative Route
  • Drug Class
  • Patent Information
  • Molecular Formula
  • Pharmodynamics
  • Pharmacokinetics
  • Brand Names
  • Development Agreements
  • ATC Codes

1. Drug Pipeline: Preclinical

  1.1 Overview

  1.2 Drug Profile

2. Drug Pipeline: Phase I

  2.1 Overview

  2.2 Drug Profile

3. Drug Pipeline: Phase-I/II

  3.1 Overview

  3.2 Drug Profile

4. Drug Pipeline: Phase-II

  4.1 Overview

  4.2 Drug Profile

5. Drug Pipeline: Phase-II/III

  5.1 Overview

  5.2 Drug Profile

6. Drug Pipeline: Phase-III

  6.1 Overview

  6.2 Drug Profile

7. Drug Pipeline: Preregistration

  7.1 Overview

  7.2 Drug Profile


Each Drug Profile has Tables Representing Following Information:

• Alternate Names

• Originator & Owner

• Collaborator

• Technology Provider

• Licensee

• Highest Development Phase

• Indications

• Class

• Mechanism of Action

• ATC code

• Designated Brand Name & Orphan Designation